MEDIA

Karen Pinachyan joins LFB as Executive Vice President, Scientific, Medical & Regulatory Affairs

LFB Biomanufacturing site in Alès will double its biomedicinal production capacity (PDF)

LFB announces the extension of the indications of WILFACTIN® / WILLFACT® to the entire paediatric population in the European Union (PDF)